Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Wockhardt Limited
  6. Summary
    WOCKPHARMA   INE049B01025

WOCKHARDT LIMITED

(WOCKPHARMA)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Nse India Stock Exchange
06/10/2021 06/11/2021 06/14/2021 06/15/2021 06/16/2021 Date
663.4(c) 659.4(c) 646.55(c) 642.1(c) 634.6 Last
557 398 557 909 487 059 382 739 245 238 Volume
+1.00% -0.60% -1.95% -0.69% -1.17% Change
More quotes
Financials
Sales 2020 28 440 M 388 M 388 M
Net income 2020 -692 M -9,43 M -9,43 M
Net Debt 2020 33 541 M 457 M 457 M
P/E ratio 2020 -27,6x
Yield 2020 -
Sales 2021 27 083 M 369 M 369 M
Net income 2021 6 861 M 93,5 M 93,5 M
Net Debt 2021 15 852 M 216 M 216 M
P/E ratio 2021 6,68x
Yield 2021 -
Capitalization 71 133 M 970 M 970 M
EV / Sales 2020 1,85x
EV / Sales 2021 2,28x
Nbr of Employees 5 000
Free-Float 60,4%
More Financials
Company
Wockhardt Limited is a pharmaceutical and biotechnology company. The Company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. Its products include Ace Proxyvon, Bio-Corneum, Aceroc, Alphadopa, Biovac Typhoid, Acetic Acid Otic Solution, Amlodipine Besylate Tablets, Adenosine Injection, Amoxicillin and... 
Sector
Pharmaceuticals
Calendar
07/30Earnings Release
More about the company
All news about WOCKHARDT LIMITED
05/28WOCKHARDT  : Swings to Loss in Fiscal Q4
MT
04/22WOCKHARDT  : Plans to Issue Debentures Worth $20 Million
MT
04/07WOCKHARDT  : CARE Ratings Gives BBB- Rating on Wockhardt's Proposed Non-Converti..
MT
02/11WOCKHARDT  : UK Government Announces COVID-19 Vaccination Contract Extension wit..
AQ
02/10WOCKHARDT  : UK extends COVID-19 vaccine supply deal with India's Wockhardt
RE
02/01WOCKHARDT  : profitability for Q3FY21 at Rs.15 crore
AQ
01/30WOCKHARDT  : Man arrested over package sent to vaccine plant in Wales
AQ
01/27WOCKHARDT  : UK vaccine plant evacuated after getting suspicious package
AQ
2020Factbox-Will Brexit slow Britain's COVID vaccine supplies?
RE
2020WOCKHARDT  : hosts visit of Prime Minister of United Kingdom
AQ
2020Indian drugmaker Biological E. to make substance used in J&J's potential COVI..
RE
2020ASTRAZENECA  : Wockhardt strikes deal to supply COVID-19 vaccines to UK
RE
2020ASTRAZENECA  : India's Wockhardt strikes deal to supply COVID-19 vaccines to UK
RE
2020WOCKHARDT  : India's Wockhardt strikes deal to supply COVID-19 vaccines to UK
RE
2020WOCKHARDT  : India's Wockhardt to make COVID-19 vaccines for UK
RE
More news
News in other languages on WOCKHARDT LIMITED
01/28Eine Festnahme nach verdächtigem Paketfund bei Astrazeneca-Zulieferer
01/27Verdächtiges Paket bei Impfstoffhersteller Astrazeneca gesichert
01/27Verdächtiges Paket bei Impfstoffhersteller Astrazeneca entdeckt
2012WOCKHARDT : finalisation de la vente de sa division nutrition à Danone
More news
Chart WOCKHARDT LIMITED
Duration : Period :
Wockhardt Limited Technical Analysis Chart | WOCKPHARMA | INE049B01025 | MarketScreener
Technical analysis trends WOCKHARDT LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Managers and Directors
NameTitle
Murtaza Habil Khorakiwala Managing Director & Executive Director
Manas Datta Chief Financial Officer & Press Contact
Habil Fakhruddin Khorakiwala Chairman
Gajanand Sahu Secretary & Compliance Officer
Aman Som Mehta Independent Non-Executive Director
Sector and Competitors